Nanobots Market Growth Accelerated by Increasing Demand for Minimally Invasive Procedures, Projected to Reach US$ 13.87 Billion by 2031: Growth Plus Reports Study
Growth Plus Reports
6 min read
Growth Plus Reports
Newark, New Castle, USA, April 05, 2023 (GLOBE NEWSWIRE) -- The global nanobots market is expected to reach US$ 13.87 billion by 2031, with a revenue CAGR of 10.10%, according to new Growth Plus Reports research. The research examines key trends, opportunities, competition, industry dynamics, market size, statistics and projections, and territories.
Key Takeaways:
The growing prevalence of chronic diseases will drive the market's revenue growth.
Increasing demand for targeted therapies will drive demand for nanobots.
North America dominates the global nanobots market.
North America, Europe, Asia Pacific, and the Rest of the World (ROW)
Market Drivers The growing prevalence of chronic diseases including cancer, diabetes, and cardiovascular diseases will drive the nanobot market's revenue growth. Furthermore, increased demand for minimally invasive procedures, targeted therapies, and technological advancements are expected to boost the market revenue growth rate. Additionally, increasing investment in R&D is expected to support the market's revenue growth.
Market Segmentation Growth Plus Reports has analyzed the global nanobots market from four perspectives: Product Type, Application, End-user, and Region.
Product Type Segmentation: Based on the product type, the nanobots market is segmented into nanomanipulator, bio-nanorobotics, magnetically guided, and bacteria-based. The nanomanipulator segment dominates the market with the largest revenue share because it helps scientists and researchers and can magnify an image up to 1,000,000 times its original size.
Application Segmentation: Based on the application, the nanobots market is segmented into nanomedicine, biomedical, drug delivery, medical imaging, and others. Nanomedicine segment dominates the market because it can revolutionize disease diagnosis, treatment, and prevention, and nanomedicine is at the front of the evolution.
End-User Segmentation: Based on the end-user, the nanobots market is segmented into the pharmaceutical industry, research institutes, hospitals, and others. Research institutes segment dominates the market because they are critical in developing and commercializing nanobots for therapeutic purposes.
Regional Growth Dynamics Based on the region, the global nanobots market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America dominates the global nanobots market, with the largest revenue share of the market. The domicile of key market players, fast adoption of technology, rising governmental healthcare spending, increased R&D, and advanced research infrastructure are responsible for North America's revenue share in the market.
Some key players operating in the global nanobots market are:
· Thermo Fischer Scientific Inc. · Imina Technologies SA · Nanoics Imaging Limited · Toronto Nano Instrumentation Inc. · Zymergen Inc. · Oxford Instruments · Hitachi, Ltd. · Klocke Nanotechnik GmbH · Bruker Corporation · EV Group (EVG)
The nanobots market is somewhat competitive with several global corporations involved. Leading companies invest in technological advancements, research, development, mergers, and acquisitions to strengthen their market position and increase geographical footprint.
Recent developments:
· Max Planck Institute for Intelligent Systems developed "micro rollers" in December 2021 that can move through the body and antibodies to identify cancerous cells.
· Tescan Orsay Holding introduced the nanomanipulator, a fully integrated system that enables lift-out and micro- and nanoscale manipulation on TESCAN SEM and FIB-SEM devices at room temperature and cryo settings, in February 2021. The TESCAN Nanomanipulator is an excellent choice for applications such as TEM lamella lift-out, prototype manipulation, and local charge dissipation that do not need sample rotation or advanced manipulation capabilities. TESCAN's design reduces vibration during lift-out or manipulation, resulting in smooth and predictable movement.
Table of Content
INTRODUCTION
Market Ecosystem
Timeline Under Consideration
Historical Years – 2021
Base Year – 2022
Forecast Years – 2023 to 2031
Currency Used in the Report
RESEARCH METHODOLOGY
Research Approach
Data Collection Methodology
Data Sources
Secondary Sources
Primary Sources
Market Estimation Approach
Bottom Up
Top Down
Market Forecasting Model
Limitations and Assumptions
PREMIUM INSIGHTS
Current Market Trends (COVID-19 Perspective)
Key Players & Competitive Positioning (2022)
Regulatory Landscape
Reimbursements
MARKET DYNAMICS
Drivers
Restraints/Challenges
Opportunities
GLOBAL NANOBOTS MARKET - ANALYSIS & FORECAST, BY PRODUCT TYPE
Nanomanipulator
Bio-Nanorobotics
Magnetically Guided
Bacteria-Based
GLOBAL NANOBOTS MARKET - ANALYSIS & FORECAST, BY APPLICATION
Medical Coding Market by Classification System (International Classification of Diseases (ICD)), Component (Outsourced), End User (Hospital) – Global Outlook & Forecast 2023-2031
Interventional X-Ray Contrast Systems Market by Product Type (Iodinated Contrast-Media, Gadolinium-Based Contrast Media), Application (Cardiology, Neurology, Oncology)-Global Outlook & Forecast 2023-2031
Foot and Ankle Plating System Market by Application (Ankle Fusion, Forefoot & Midfoot Fusion), Material (Stainless Steel Plates, Titanium Plates), End User (Hospitals, Orthopedic Centers) – Global Outlook & Forecast 2023-2031
Facet Joint Injections Market by Product Type (Local Anesthesia, Steroids), Application (Cervical Facet Joints, Lumber Facet Joints), End User (Hospitals, Outpatient Centers) - Global Outlook and Forecast 2023-2031
Enteral Feeding Devices Market by Product (Enteral Feeding Pumps, Enteral Feeding Tubes, Enterostomy Feeding Tubes, Nasoenteric Feeding Tubes), Age Group (Pediatrics, Adults) Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care), End User (Hospitals & Home Care) – Global Outlook & Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
